Company Filing History:
Years Active: 2012
Title: Kori Wallace: Innovator in Sickle Cell Disease Treatment
Introduction
Kori Wallace is a prominent inventor based in Charlottesville, VA (US). She has made significant contributions to the field of medical research, particularly in the treatment of sickle cell disease. Her innovative approach has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
Kori Wallace holds a patent for a method to treat sickle cell disease. The patent describes a therapeutic method for addressing the inflammatory response caused by a sickle cell crisis. This method involves the administration of an effective amount of an adenosine receptor agonist. Additionally, the method may include the administration of a type IV PDE inhibitor, such as rolipram. This innovative treatment approach highlights her commitment to advancing medical science.
Career Highlights
Kori Wallace is associated with the University of Virginia Patent Foundation, where she continues to work on groundbreaking research. Her dedication to her field is evident in her innovative patent and her ongoing contributions to medical research.
Collaborations
Kori has collaborated with notable colleagues, including Joel M. Linden and Robert Alan Figler. These partnerships have further enhanced her research and development efforts in the medical field.
Conclusion
Kori Wallace is a trailblazer in the treatment of sickle cell disease, with her innovative patent showcasing her expertise and dedication. Her work has the potential to make a significant impact on the lives of those affected by this condition.